Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients

NCT00721773 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Renal Function Disorder

Interventions

DRUG: Benazepril
DRUG: Valsartan
DRUG: Benazepril+Valsartan
DRUG: Control

Sponsor

Sun Yat-sen University